Samuel Whiting
2022
In 2022, Samuel Whiting earned a total compensation of $833.4K as Chief Medical Officer at OvaScience, which was about the same as previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $142,025 |
|---|---|
| Option Awards | $242,173 |
| Salary | $437,000 |
| Other | $12,200 |
| Total | $833,398 |
Whiting received $437K in salary, accounting for 52% of the total pay in 2022.
Whiting also received $142K in non-equity incentive plan, $242.2K in option awards and $12.2K in other compensation.
Rankings
In 2022, Samuel Whiting's compensation ranked 3,407th out of 5,736 executives tracked by ExecPay. In other words, Whiting earned more than 40.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,407 out of 5,736 | 41st |
Division Manufacturing | 1,930 out of 3,125 | 38th |
Major group Chemicals And Allied Products | 924 out of 1,416 | 35th |
Industry group Drugs | 864 out of 1,317 | 34th |
Industry Pharmaceutical Preparations | 630 out of 963 | 35th |
Source: SEC filing on May 1, 2023.
Whiting's colleagues
We found two more compensation records of executives who worked with Samuel Whiting at OvaScience in 2022.